DK1228097T3 - Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge - Google Patents

Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge

Info

Publication number
DK1228097T3
DK1228097T3 DK00981916T DK00981916T DK1228097T3 DK 1228097 T3 DK1228097 T3 DK 1228097T3 DK 00981916 T DK00981916 T DK 00981916T DK 00981916 T DK00981916 T DK 00981916T DK 1228097 T3 DK1228097 T3 DK 1228097T3
Authority
DK
Denmark
Prior art keywords
human lactoferrin
cluster
antimicrobial activity
polypeptides
cationic
Prior art date
Application number
DK00981916T
Other languages
English (en)
Inventor
Berkel Patrick Hendrikus C Van
Peter Hendrikus Nibbering
Jan Henricus Nuijens
Original Assignee
Am Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Pharma Bv filed Critical Am Pharma Bv
Application granted granted Critical
Publication of DK1228097T3 publication Critical patent/DK1228097T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK00981916T 1999-11-11 2000-11-10 Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge DK1228097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16497599P 1999-11-11 1999-11-11
EP99203775 1999-11-11

Publications (1)

Publication Number Publication Date
DK1228097T3 true DK1228097T3 (da) 2006-04-18

Family

ID=26153390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00981916T DK1228097T3 (da) 1999-11-11 2000-11-10 Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge

Country Status (11)

Country Link
EP (1) EP1228097B1 (da)
JP (1) JP2003521483A (da)
AT (1) ATE313562T1 (da)
AU (1) AU776044B2 (da)
CA (1) CA2388910C (da)
CY (1) CY1105008T1 (da)
DE (1) DE60025026T2 (da)
DK (1) DK1228097T3 (da)
ES (1) ES2256070T3 (da)
PT (1) PT1228097E (da)
WO (1) WO2001034641A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4486501A (en) * 2000-03-27 2001-10-08 Pharming Intellectual Property Bv High dosage parenteral administration of lactoferrin
AU2002236477A1 (en) 2000-11-21 2002-06-03 The Texas A & M University System Fgf-affinity chromatography
EP1360961A1 (en) * 2002-05-07 2003-11-12 AM-Pharma B.V. Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
EP1653987A4 (en) * 2003-07-16 2006-08-09 Univ New York State Res Found HOST DEFENSE FACTOR X (HDFX)
WO2007055578A1 (en) * 2005-11-11 2007-05-18 Leids Universitair Medisch Centrum Cyclic antimicrobial peptides derived from lactoferrin
AU2007272272B2 (en) * 2006-07-10 2012-04-12 Pba3 Biomed Gmbh Antimicrobial peptides
EP2030980A1 (en) * 2007-08-28 2009-03-04 AM-Pharma B.V. Mutants of lactoferrin
EP2050461A1 (en) 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
EP2060586A1 (en) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB New synthetic arginine substituted peptides and their use
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
JP6099055B2 (ja) * 2014-05-09 2017-03-22 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 変性病変の診断のためのリガンドとしてのフコイダン
CN107304424B (zh) * 2016-05-23 2019-05-10 成都福际生物技术有限公司 改造的转铁蛋白dna结合域、重组dna聚合酶及制备方法
EP3737750B1 (en) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
KR20220005560A (ko) 2019-05-06 2022-01-13 신세틱 바이오로직스, 인코퍼레이티드 알칼리성 포스페이트-기반 종양학 치료제
US20230190652A1 (en) * 2020-04-16 2023-06-22 Dermopartners,S.L. Composition for the treatment of covid-19 and treatment method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2941093B2 (ja) * 1990-06-26 1999-08-25 森永乳業株式会社 ラクトフェリン分解物を有効成分とするチロシナーゼ活性阻害剤及びラクトフェリン分解物を用いる物品の処理方法
JP3173857B2 (ja) * 1991-04-24 2001-06-04 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) * 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3261175B2 (ja) * 1992-01-23 2002-02-25 森永乳業株式会社 抗菌剤とこの抗菌剤を用いて物品を処理する方法
AU1809895A (en) * 1994-02-16 1995-09-04 Pharming Bv Isolation of lactoferrin from milk
JP3506274B2 (ja) * 1994-09-01 2004-03-15 雪印乳業株式会社 新規ペプチドおよび免疫賦活剤
JPH09165342A (ja) * 1995-12-14 1997-06-24 Morinaga Milk Ind Co Ltd 抗真菌剤
JPH1192375A (ja) * 1997-09-25 1999-04-06 Morinaga Milk Ind Co Ltd ニューキノロン系抗菌剤の抗菌性を増強させる抗菌剤

Also Published As

Publication number Publication date
EP1228097A2 (en) 2002-08-07
CA2388910A1 (en) 2001-05-17
JP2003521483A (ja) 2003-07-15
WO2001034641A8 (en) 2002-05-10
PT1228097E (pt) 2006-05-31
CY1105008T1 (el) 2009-11-04
CA2388910C (en) 2008-10-07
DE60025026D1 (de) 2006-01-26
EP1228097B1 (en) 2005-12-21
ES2256070T3 (es) 2006-07-16
DE60025026T2 (de) 2006-08-03
WO2001034641A2 (en) 2001-05-17
WO2001034641A3 (en) 2002-02-14
AU1901501A (en) 2001-06-06
ATE313562T1 (de) 2006-01-15
AU776044B2 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
HRP20020880B1 (en) New pharmaceutical composition
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
LTC1131065I2 (lt) Dialkilfumaratai, skirti autoimuninėms ligoms gydyti
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
TR200100054T2 (tr) Paroksetin metansülfonat
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
ATE398630T1 (de) Zyklische conotoxin-peptide
DE60033649D1 (de) Verbindungen und therapeutische methoden
DE69819145D1 (de) Bioabbaubare mikropartikeln mit verzögerter wirkstofffreisetzung
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
DE60125232D1 (de) Kleines säurelösliches sporenprotein und seine verwendungen
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
MXPA02012015A (es) Ligandos de receptores para integrinas.
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
DE60003074D1 (de) Fusidinsäure-derivate
ATE287716T1 (de) Metallsalze als antimykotika
HUP0202888A2 (hu) Xenogén oligo- és/vagy poliribonukleotidokat tartalmazó gyógyszerkészítmény
RU2003124254A (ru) Косметическое средство для ухода за кожей лица и шеи
ATE402178T1 (de) Substituierte 5,6,6a,11b-tetrahydro-7-oxa-5-aza- benzoäcüfluoren-6-carbonsäurederivate als nmda- antagonisten